Inhalative Nanoparticulate CpG Immunotherapy in Severe Equine Asthma: An Innovative Therapeutic Concept and Potential Animal Model for Human Asthma Treatment

Severe equine asthma is the most common globally widespread non-infectious equine respiratory disease (together with its mild and moderate form), which is associated with exposure to hay dust and mold spores, has certain similarities to human asthma, and continues to represent a therapeutic problem....

Full description

Saved in:
Bibliographic Details
Published inAnimals (Basel) Vol. 12; no. 16; p. 2087
Main Authors Klier, John, Fuchs, Sebastian, Winter, Gerhard, Gehlen, Heidrun
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 16.08.2022
MDPI
Subjects
Airway management
allergy
animal models
anti-allergic agents
Antigens
Asthma
breathing
Cell cycle
Chronic obstructive pulmonary disease
CpG
Cytokines
drug delivery systems
dust
gelatin
gelatinase A
gene expression
Genes
Genotype & phenotype
Granulocytes
Horses
humans
Hyperplasia
immunotherapy
Insect bites
interleukin-10
interleukin-4
interleukin-8
mucus
nanoparticle
nanoparticles
Neutrophils
oligodeoxyribonucleotides
oxygen partial pressure
Parasites
Pathophysiology
Physiology
Remission (Medicine)
Review
Steroids
Urticaria
viscosity
Online AccessGet full text
ISSN2076-2615
2076-2615
DOI10.3390/ani12162087

Cover

Abstract Severe equine asthma is the most common globally widespread non-infectious equine respiratory disease (together with its mild and moderate form), which is associated with exposure to hay dust and mold spores, has certain similarities to human asthma, and continues to represent a therapeutic problem. Immunomodulatory CpG-ODN, bound to gelatin nanoparticles as a drug delivery system, were successfully administered by inhalation to severe equine asthmatic patients in several studies. It was possible to demonstrate a significant, sustained, and allergen-independent one-to-eight-week improvement in key clinical parameters: the arterial partial pressure of oxygen, the quantity and viscosity of tracheal mucus, and neutrophilic inflammatory cells in the respiratory tracts of the severe equine asthmatic subjects. At the immunological level, an upregulation of the regulatory antiallergic and anti-inflammatory cytokine IL-10 as well as a downregulation of the proallergic IL-4 and proinflammatory IFN-γ in the respiratory tracts of the severe equine asthmatic patients were identified in the treatment groups. CD4+ T lymphocytes in the respiratory tracts of the asthmatic horses were demonstrated to downregulate the mRNA expression of Tbet and IL-8. Concentrations of matrix metalloproteinase-2 and -9 and tissue inhibitors of metalloproteinase-2 were significantly decreased directly after the treatment as well as six weeks post-treatment. This innovative therapeutic concept thus opens new perspectives in the treatment of severe equine asthma and possibly also that of human asthma.
AbstractList Severe equine asthma is the most common globally widespread non-infectious equine respiratory disease (together with its mild and moderate form), which is associated with exposure to hay dust and mold spores, has certain similarities to human asthma, and continues to represent a therapeutic problem. Immunomodulatory CpG-ODN, bound to gelatin nanoparticles as a drug delivery system, were successfully administered by inhalation to severe equine asthmatic patients in several studies. It was possible to demonstrate a significant, sustained, and allergen-independent one-to-eight-week improvement in key clinical parameters: the arterial partial pressure of oxygen, the quantity and viscosity of tracheal mucus, and neutrophilic inflammatory cells in the respiratory tracts of the severe equine asthmatic subjects. At the immunological level, an upregulation of the regulatory antiallergic and anti-inflammatory cytokine IL-10 as well as a downregulation of the proallergic IL-4 and proinflammatory IFN-γ in the respiratory tracts of the severe equine asthmatic patients were identified in the treatment groups. CD4+ T lymphocytes in the respiratory tracts of the asthmatic horses were demonstrated to downregulate the mRNA expression of Tbet and IL-8. Concentrations of matrix metalloproteinase-2 and -9 and tissue inhibitors of metalloproteinase-2 were significantly decreased directly after the treatment as well as six weeks post-treatment. This innovative therapeutic concept thus opens new perspectives in the treatment of severe equine asthma and possibly also that of human asthma.
Simple SummarySevere equine asthma is the most common globally widespread non-infectious equine respiratory disease (together with its mild and moderate form), which is associated with exposure to hay dust and mold spores, has certain similarities to human asthma, and continues to represent a therapeutic problem. Immunomodulatory DNA sequences (CpG) bound to nanoparticles were successfully administered by inhalation to severe asthmatic horses in several studies. It was possible to demonstrate a significant, sustained, one-to-eight-week improvement in important clinical parameters: partial oxygen pressure in the blood, quantity and viscosity of tracheal mucus secretion in the airways, and the amount of inflammatory cells in the respiratory tracts of severe asthmatic horses. The immunotherapy with CpG is performed independent of specific allergens. At an immunological level, the treatment leads to decreases in allergic and inflammatory parameters. This innovative therapeutic concept thus opens new perspectives in severe equine asthma treatment and possibly also in human asthma treatment.AbstractSevere equine asthma is the most common globally widespread non-infectious equine respiratory disease (together with its mild and moderate form), which is associated with exposure to hay dust and mold spores, has certain similarities to human asthma, and continues to represent a therapeutic problem. Immunomodulatory CpG-ODN, bound to gelatin nanoparticles as a drug delivery system, were successfully administered by inhalation to severe equine asthmatic patients in several studies. It was possible to demonstrate a significant, sustained, and allergen-independent one-to-eight-week improvement in key clinical parameters: the arterial partial pressure of oxygen, the quantity and viscosity of tracheal mucus, and neutrophilic inflammatory cells in the respiratory tracts of the severe equine asthmatic subjects. At the immunological level, an upregulation of the regulatory antiallergic and anti-inflammatory cytokine IL-10 as well as a downregulation of the proallergic IL-4 and proinflammatory IFN-γ in the respiratory tracts of the severe equine asthmatic patients were identified in the treatment groups. CD4+ T lymphocytes in the respiratory tracts of the asthmatic horses were demonstrated to downregulate the mRNA expression of Tbet and IL-8. Concentrations of matrix metalloproteinase-2 and -9 and tissue inhibitors of metalloproteinase-2 were significantly decreased directly after the treatment as well as six weeks post-treatment. This innovative therapeutic concept thus opens new perspectives in the treatment of severe equine asthma and possibly also that of human asthma.
Severe equine asthma is the most common globally widespread non-infectious equine respiratory disease (together with its mild and moderate form), which is associated with exposure to hay dust and mold spores, has certain similarities to human asthma, and continues to represent a therapeutic problem. Immunomodulatory CpG-ODN, bound to gelatin nanoparticles as a drug delivery system, were successfully administered by inhalation to severe equine asthmatic patients in several studies. It was possible to demonstrate a significant, sustained, and allergen-independent one-to-eight-week improvement in key clinical parameters: the arterial partial pressure of oxygen, the quantity and viscosity of tracheal mucus, and neutrophilic inflammatory cells in the respiratory tracts of the severe equine asthmatic subjects. At the immunological level, an upregulation of the regulatory antiallergic and anti-inflammatory cytokine IL-10 as well as a downregulation of the proallergic IL-4 and proinflammatory IFN-γ in the respiratory tracts of the severe equine asthmatic patients were identified in the treatment groups. CD4⁺ T lymphocytes in the respiratory tracts of the asthmatic horses were demonstrated to downregulate the mRNA expression of Tbet and IL-8. Concentrations of matrix metalloproteinase-2 and -9 and tissue inhibitors of metalloproteinase-2 were significantly decreased directly after the treatment as well as six weeks post-treatment. This innovative therapeutic concept thus opens new perspectives in the treatment of severe equine asthma and possibly also that of human asthma.
Severe equine asthma is the most common globally widespread non-infectious equine respiratory disease (together with its mild and moderate form), which is associated with exposure to hay dust and mold spores, has certain similarities to human asthma, and continues to represent a therapeutic problem. Immunomodulatory CpG-ODN, bound to gelatin nanoparticles as a drug delivery system, were successfully administered by inhalation to severe equine asthmatic patients in several studies. It was possible to demonstrate a significant, sustained, and allergen-independent one-to-eight-week improvement in key clinical parameters: the arterial partial pressure of oxygen, the quantity and viscosity of tracheal mucus, and neutrophilic inflammatory cells in the respiratory tracts of the severe equine asthmatic subjects. At the immunological level, an upregulation of the regulatory antiallergic and anti-inflammatory cytokine IL-10 as well as a downregulation of the proallergic IL-4 and proinflammatory IFN-γ in the respiratory tracts of the severe equine asthmatic patients were identified in the treatment groups. CD4+ T lymphocytes in the respiratory tracts of the asthmatic horses were demonstrated to downregulate the mRNA expression of Tbet and IL-8. Concentrations of matrix metalloproteinase-2 and -9 and tissue inhibitors of metalloproteinase-2 were significantly decreased directly after the treatment as well as six weeks post-treatment. This innovative therapeutic concept thus opens new perspectives in the treatment of severe equine asthma and possibly also that of human asthma.Severe equine asthma is the most common globally widespread non-infectious equine respiratory disease (together with its mild and moderate form), which is associated with exposure to hay dust and mold spores, has certain similarities to human asthma, and continues to represent a therapeutic problem. Immunomodulatory CpG-ODN, bound to gelatin nanoparticles as a drug delivery system, were successfully administered by inhalation to severe equine asthmatic patients in several studies. It was possible to demonstrate a significant, sustained, and allergen-independent one-to-eight-week improvement in key clinical parameters: the arterial partial pressure of oxygen, the quantity and viscosity of tracheal mucus, and neutrophilic inflammatory cells in the respiratory tracts of the severe equine asthmatic subjects. At the immunological level, an upregulation of the regulatory antiallergic and anti-inflammatory cytokine IL-10 as well as a downregulation of the proallergic IL-4 and proinflammatory IFN-γ in the respiratory tracts of the severe equine asthmatic patients were identified in the treatment groups. CD4+ T lymphocytes in the respiratory tracts of the asthmatic horses were demonstrated to downregulate the mRNA expression of Tbet and IL-8. Concentrations of matrix metalloproteinase-2 and -9 and tissue inhibitors of metalloproteinase-2 were significantly decreased directly after the treatment as well as six weeks post-treatment. This innovative therapeutic concept thus opens new perspectives in the treatment of severe equine asthma and possibly also that of human asthma.
Author Winter, Gerhard
Klier, John
Gehlen, Heidrun
Fuchs, Sebastian
AuthorAffiliation 3 Equine Clinic, Surgery and Radiology, Department of Veterinary Medicine, Free University of Berlin, 14163 Berlin, Germany
2 Pharmaceutical Technology and Biopharmaceutics, Faculty of Chemistry and Pharmacy, Ludwig-Maximilians-University, 81377 Munich, Germany
1 Equine Clinic, Centre for Clinical Veterinary Medicine, Ludwig-Maximilians-University, 85764 Oberschleißheim, Germany
AuthorAffiliation_xml – name: 2 Pharmaceutical Technology and Biopharmaceutics, Faculty of Chemistry and Pharmacy, Ludwig-Maximilians-University, 81377 Munich, Germany
– name: 3 Equine Clinic, Surgery and Radiology, Department of Veterinary Medicine, Free University of Berlin, 14163 Berlin, Germany
– name: 1 Equine Clinic, Centre for Clinical Veterinary Medicine, Ludwig-Maximilians-University, 85764 Oberschleißheim, Germany
Author_xml – sequence: 1
  givenname: John
  orcidid: 0000-0002-0506-0518
  surname: Klier
  fullname: Klier, John
– sequence: 2
  givenname: Sebastian
  surname: Fuchs
  fullname: Fuchs, Sebastian
– sequence: 3
  givenname: Gerhard
  surname: Winter
  fullname: Winter, Gerhard
– sequence: 4
  givenname: Heidrun
  orcidid: 0000-0001-5451-4232
  surname: Gehlen
  fullname: Gehlen, Heidrun
BookMark eNqNkltrFDEUgAep2Fr75B8I-CLoai6Ty_ggLEttF-oFXJ-HM9kz3SwzyTQzs7I_xv9q9oK0RdA85ITky0dOznmenfjgMcteMvpOiIK-B-8YZ4pTo59kZ5xqNeGKyZN769Psou_XNA0tBZPsWXYqFKWF0vos-zX3K2hgcBskX8CHDuLg7Jh2kMy6KzJv29GHYYURui1xnnzHDUYkl3ej80im_bBq4QOZejL3PmwOosUexzGZyCx4i91AwC_JtzCgHxw0iXdtCp_DEhtSh0iuxxb8UUcWEWFoE_oie1pD0-PFMZ5nPz5dLmbXk5uvV_PZ9GZicyOHiZBcK1lrQa0qpEXkhmnDDVJVmLoSRisA1IUxjIHKlwWvOChpOa3rmgIV59n84F0GWJddTI-L2zKAK_cbId6W-39psFR1oUSa8rpY5rLCouKMa5nbqpYGmE2utwfX6DvY_oSm-SNktNwVrbxXtIR_PODdWLW4tCnrCM2DNzw88W5V3oZNWeRUCpEnweujIIa7EfuhbF1vsWnAYxj7kmtmhDYp-f9AU89QljOV0FeP0HUYo09F2FGKqlxxkag3B8rG0PcR63-kyh7R1g2pY8IuMdf89c5vyP7oaw
CitedBy_id crossref_primary_10_12968_ukve_2024_8_1_5
crossref_primary_10_3390_ani13182952
crossref_primary_10_1007_s11244_024_01919_7
crossref_primary_10_1016_j_tvjl_2024_106125
crossref_primary_10_1016_j_jevs_2024_105033
Cites_doi 10.1111/evj.13419
10.1016/S0165-2427(01)00420-2
10.1016/j.bbrc.2004.04.067
10.1016/j.vetimm.2005.07.013
10.1111/j.1439-0442.2007.00870.x
10.1111/j.1939-1676.2006.tb02875.x
10.1002/eji.200535210
10.1155/2019/7845623
10.1016/0165-2427(93)90081-E
10.1002/iid3.198
10.1111/j.1939-1676.2009.0292.x
10.2460/ajvr.1998.59.08.1033
10.1002/iid3.252
10.1038/ni1122
10.1016/j.vetimm.2021.110351
10.1152/ajplung.2000.278.4.L667
10.4049/jimmunol.172.3.1777
10.1055/b-004-129693
10.1038/s41598-019-51820-7
10.1097/00130832-200310000-00001
10.1146/annurev.immunol.20.100301.064842
10.1080/01652176.2020.1745317
10.4049/jimmunol.162.4.2368
10.1111/j.1365-2567.2006.02321.x
10.1007/s11095-012-0686-8
10.1111/j.1365-2222.2008.03191.x
10.1111/j.2042-3306.1991.tb02738.x
10.1016/j.addr.2008.12.014
10.2460/ajvr.2000.61.1369
10.1016/j.vetimm.2011.07.009
10.2460/ajvr.2005.66.1665
10.4049/jimmunol.181.5.2990
10.1111/evj.12289
10.1136/vr.104230
10.1378/chest.130.1_suppl.4S
10.1007/s12026-007-0083-2
10.1111/j.2042-3306.1998.tb04475.x
10.4049/jimmunol.173.7.4433
10.1186/1476-8518-5-1
10.1016/S0165-2427(98)00202-5
10.1002/ar.20927
10.1111/j.1365-3164.2005.00426.x
10.1165/rcmb.2017-0228OC
10.1016/j.vetimm.2004.12.013
10.1189/jlb.68.4.455
10.1159/000066771
10.1111/j.1440-1843.2011.02033.x
10.3390/ani12060744
10.1016/j.vetimm.2006.07.013
10.1007/s11095-007-9410-5
10.1165/rcmb.2011-0363OC
10.1111/jvim.12524
10.1016/j.jconrel.2004.02.022
10.1016/j.vetimm.2009.09.011
10.1128/JVI.01337-19
10.1159/000062171
10.1016/j.immuni.2008.01.013
10.1016/j.jaci.2007.02.023
10.1111/j.1939-1676.2009.0382.x
10.2746/042516402776181105
10.1111/evj.13018
10.2460/ajvr.1998.59.08.1039
10.1016/S0165-2427(03)00142-9
10.1111/j.1398-9995.2009.01972.x
10.2460/ajvr.2002.63.579
10.1016/j.vetimm.2003.08.013
10.1016/j.biomaterials.2009.03.010
10.1016/j.addr.2008.12.007
10.3389/fvets.2018.00061
10.1111/j.0105-2896.2006.00413.x
10.4049/jimmunol.180.6.3797
10.1111/jvim.15302
10.17221/1566-VETMED
10.1016/j.tvjl.2016.11.013
10.3109/02652048.2012.668962
10.1016/S0952-7915(99)00045-X
10.1038/ni1028
10.1016/j.jevs.2021.103433
10.21836/PEM20090405
10.1002/eji.200526124
10.1111/evj.12204
10.1016/j.addr.2008.12.008
10.1016/j.cell.2006.02.015
10.3389/fimmu.2021.590054
10.1111/jvim.13824
10.1016/j.cveq.2020.03.005
10.3389/fvets.2020.00450
10.2746/042516407X180129
10.3390/genes11101143
10.1164/ajrccm.164.8.2012091
10.1007/s40521-014-0038-5
10.1016/j.biomaterials.2008.03.033
10.1111/evj.13093
10.1016/j.molimm.2014.12.005
10.1038/374546a0
10.2746/042516409X479586
10.1038/321209a0
10.1111/j.1398-9995.2004.00645.x
ContentType Journal Article
Copyright 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 by the authors. 2022
Copyright_xml – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 by the authors. 2022
DBID AAYXX
CITATION
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
7S9
L.6
5PM
ADTOC
UNPAY
DOA
DOI 10.3390/ani12162087
DatabaseName CrossRef
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DOAJ Open Access Full Text
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Central China
ProQuest Central
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList CrossRef
Publicly Available Content Database
AGRICOLA
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Zoology
EISSN 2076-2615
ExternalDocumentID oai_doaj_org_article_6f9636f94f9d45be9b212754cbf58a1c
10.3390/ani12162087
PMC9405334
10_3390_ani12162087
GroupedDBID 5VS
7XC
8FE
8FH
AAFWJ
AAHBH
AAYXX
ABDBF
ACUHS
AFKRA
AFPKN
ALMA_UNASSIGNED_HOLDINGS
APEBS
BENPR
CCPQU
CITATION
DIK
EAD
EAP
EPL
ESX
GROUPED_DOAJ
HYE
IAO
ITC
LK8
M48
MODMG
M~E
OK1
OZF
PGMZT
PHGZM
PHGZT
PIMPY
PROAC
RPM
TUS
ZBA
ABUWG
AZQEC
DWQXO
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
PUEGO
7S9
L.6
5PM
ADRAZ
ADTOC
IPNFZ
RIG
UNPAY
ID FETCH-LOGICAL-c485t-352765f730c695cee2817828e0698fb3876aae798811a64d92b2a65c20fff0a03
IEDL.DBID M48
ISSN 2076-2615
IngestDate Fri Oct 03 12:31:41 EDT 2025
Sun Oct 26 03:23:33 EDT 2025
Tue Sep 30 16:43:49 EDT 2025
Thu Oct 02 07:08:19 EDT 2025
Thu Oct 02 11:08:38 EDT 2025
Mon Jun 30 07:30:41 EDT 2025
Thu Apr 24 23:09:48 EDT 2025
Thu Oct 16 04:45:50 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 16
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
cc-by
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c485t-352765f730c695cee2817828e0698fb3876aae798811a64d92b2a65c20fff0a03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-0506-0518
0000-0001-5451-4232
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/ani12162087
PMID 36009677
PQID 2706064623
PQPubID 2032438
ParticipantIDs doaj_primary_oai_doaj_org_article_6f9636f94f9d45be9b212754cbf58a1c
unpaywall_primary_10_3390_ani12162087
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9405334
proquest_miscellaneous_2718378988
proquest_miscellaneous_2707601416
proquest_journals_2706064623
crossref_primary_10_3390_ani12162087
crossref_citationtrail_10_3390_ani12162087
PublicationCentury 2000
PublicationDate 20220816
PublicationDateYYYYMMDD 2022-08-16
PublicationDate_xml – month: 8
  year: 2022
  text: 20220816
  day: 16
PublicationDecade 2020
PublicationPlace Basel
PublicationPlace_xml – name: Basel
PublicationTitle Animals (Basel)
PublicationYear 2022
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Klier (ref_104) 2021; 102
ref_13
Wilson (ref_86) 2009; 61
Robinson (ref_48) 2002; 34
Halliwell (ref_14) 1993; 38
Akira (ref_62) 2006; 124
ref_17
Klier (ref_77) 2019; 7
Ammann (ref_39) 1998; 30
Gerber (ref_29) 2009; 23
Couetil (ref_41) 2006; 20
Rush (ref_40) 1998; 59
Adamus (ref_103) 2018; 22
ref_25
Krieg (ref_69) 1995; 374
Johansen (ref_91) 2005; 35
Moran (ref_5) 2011; 56
Bird (ref_66) 1986; 321
ref_28
Lavoie (ref_47) 2002; 63
Taylor (ref_82) 2006; 117
ref_27
Dickson (ref_58) 2019; 60
Klier (ref_76) 2015; 29
Fonseca (ref_64) 2009; 61
Ziegler (ref_96) 2017; 219
Latz (ref_67) 2004; 5
Ainsworth (ref_24) 2003; 96
Zwiorek (ref_72) 2008; 25
Couetil (ref_10) 2020; 7
ref_73
Hotchkiss (ref_7) 2007; 39
Weiner (ref_84) 2000; 68
Ryanna (ref_85) 2009; 64
Mazan (ref_49) 2014; 78
Wagner (ref_102) 2017; 29
Franchini (ref_19) 2000; 11
Senti (ref_89) 2009; 39
Flaminio (ref_95) 2007; 25
Bracher (ref_8) 1991; 23
Kline (ref_51) 2007; 39
Robinson (ref_44) 2009; 23
Tseng (ref_93) 2009; 30
Horohov (ref_22) 2005; 108
Moseman (ref_80) 2004; 173
Waser (ref_55) 2005; 60
McGorum (ref_33) 2008; 19
Nicod (ref_113) 2009; 139
Hiltyb (ref_57) 2020; 40
Bond (ref_11) 2018; 32
Giguere (ref_23) 2002; 85
Haas (ref_63) 2008; 28
Brzoska (ref_115) 2004; 318
Klier (ref_74) 2011; 144
Wagner (ref_18) 2009; 132
Gerber (ref_31) 2020; 36
Braman (ref_1) 2006; 130
Vollmer (ref_71) 2009; 61
Barton (ref_79) 2019; 2019
Debrue (ref_26) 2005; 105
Hartl (ref_110) 2007; 119
Mazan (ref_109) 2022; 86
Cordeau (ref_21) 2004; 97
Bourquin (ref_88) 2008; 181
Laumen (ref_35) 2010; 42
Ziegler (ref_97) 2022; 243
Tseng (ref_92) 2008; 29
ref_56
ref_53
Leclere (ref_45) 2012; 47
Pirie (ref_32) 2014; 46
Gerber (ref_30) 2015; 47
Liu (ref_114) 2008; 28
Lavoie (ref_37) 2019; 51
Klier (ref_78) 2018; 6
Bohle (ref_70) 2002; 129
White (ref_105) 2019; 23
ref_61
Jarnicki (ref_81) 2008; 180
Storni (ref_87) 2004; 172
Krieg (ref_59) 2002; 20
Fuchs (ref_94) 2012; 29
Klimek (ref_108) 2015; 2
Mutwiri (ref_106) 2004; 97
Pirie (ref_36) 2021; 53
Niedermaier (ref_50) 2009; 25
Rossi (ref_107) 2018; 5
Hansel (ref_112) 2001; Volume 31
Umetsu (ref_52) 2006; 212
(ref_54) 2003; 3
Bullone (ref_12) 2015; 66
Justice (ref_83) 2000; 278
ref_34
Lopez (ref_99) 2006; 114
Viel (ref_42) 1999; 45
Montamat (ref_116) 2021; 12
Anderson (ref_60) 2000; 12
Yasuda (ref_68) 2006; 36
Lavoie (ref_20) 2001; 164
Mueller (ref_101) 2005; 16
Couetil (ref_4) 2016; 30
Rush (ref_46) 1998; 59
Sparwasser (ref_90) 1997; 162
Couetil (ref_43) 2005; 66
Lowell (ref_6) 1964; 35
Gerber (ref_16) 2007; 54
ref_100
Klier (ref_75) 2012; 29
ref_3
Stock (ref_111) 2004; 5
Schmallenbach (ref_15) 1998; 66
ref_9
Lavoie (ref_38) 2019; 51
Schneberger (ref_65) 2009; 292
Ficarelli (ref_98) 2020; 94
Leclere (ref_2) 2011; 16
References_xml – volume: 78
  start-page: 214
  year: 2014
  ident: ref_49
  article-title: Use of a novel one-nostril mask-spacer device to evaluate airway hyperresponsiveness (AHR) in horses after chronic administration of albuterol
  publication-title: Can. J. Vet. Res.
– volume: 53
  start-page: 1094
  year: 2021
  ident: ref_36
  article-title: Inhaled ciclesonide is efficacious and well tolerated in the treatment of severe equine asthma in a large prospective European clinical trial
  publication-title: Equine Vet. J.
  doi: 10.1111/evj.13419
– volume: 85
  start-page: 147
  year: 2002
  ident: ref_23
  article-title: Cytokine induction in pulmonary airways of horses with heaves and effect of therapy with inhaled fluticasone propionate
  publication-title: Vet. Immunol. Immunopathol.
  doi: 10.1016/S0165-2427(01)00420-2
– volume: 318
  start-page: 562
  year: 2004
  ident: ref_115
  article-title: Incorporation of biodegradable nanoparticles into human airway epithelium cells—In vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2004.04.067
– volume: 108
  start-page: 237
  year: 2005
  ident: ref_22
  article-title: Temporal regulation of cytokine mRNA expression in equine recurrent airway obstruction
  publication-title: Vet. Immunol. Immunopathol.
  doi: 10.1016/j.vetimm.2005.07.013
– ident: ref_100
– volume: 54
  start-page: 40
  year: 2007
  ident: ref_16
  article-title: IgE-bearing cells in bronchoalveolar lavage fluid and allergen-specific IgE levels in sera from RAO-affected horses
  publication-title: J. Vet. Med. A Physiol. Pathol. Clin. Med.
  doi: 10.1111/j.1439-0442.2007.00870.x
– volume: 20
  start-page: 399
  year: 2006
  ident: ref_41
  article-title: Effect of beclomethasone dipropionate and dexamethasone isonicotinate on lung function, bronchoalveolar lavage fluid cytology, and transcription factor expression in airways of horses with recurrent airway obstruction
  publication-title: J. Vet. Intern. Med.
  doi: 10.1111/j.1939-1676.2006.tb02875.x
– volume: 36
  start-page: 431
  year: 2006
  ident: ref_68
  article-title: CpG motif-independent activation of TLR9 upon endosomal translocation of “natural” phosphodiester DNA
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.200535210
– volume: 2019
  start-page: 7845623
  year: 2019
  ident: ref_79
  article-title: Metalloproteinases and their Inhibitors under the Course of Immunostimulation by CPG-ODN and Specific Antigen Inhalation in Equine Asthma
  publication-title: Mediators. Inflamm.
  doi: 10.1155/2019/7845623
– volume: 38
  start-page: 201
  year: 1993
  ident: ref_14
  article-title: Local and systemic antibody production in horses affected with chronic obstructive pulmonary disease
  publication-title: Vet. Immunol. Immunopathol.
  doi: 10.1016/0165-2427(93)90081-E
– ident: ref_56
– ident: ref_27
– volume: 6
  start-page: 81
  year: 2018
  ident: ref_78
  article-title: A comparison of nanoparticulate CpG immunotherapy with and without allergens in spontaneously equine asthma-affected horses, an animal model
  publication-title: Immun. Inflamm. Dis.
  doi: 10.1002/iid3.198
– volume: 23
  start-page: 626
  year: 2009
  ident: ref_29
  article-title: Mixed inheritance of equine recurrent airway obstruction
  publication-title: J. Vet. Intern. Med.
  doi: 10.1111/j.1939-1676.2009.0292.x
– volume: 59
  start-page: 1033
  year: 1998
  ident: ref_40
  article-title: Cytologic evaluation of bronchoalveolar lavage fluid from horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively
  publication-title: Am. J. Vet. Res.
  doi: 10.2460/ajvr.1998.59.08.1033
– volume: 7
  start-page: 130
  year: 2019
  ident: ref_77
  article-title: Immunomodulatory asthma therapy in the equine animal model: A dose-response study and evaluation of a long-term effect
  publication-title: Immun. Inflamm. Dis.
  doi: 10.1002/iid3.252
– volume: 5
  start-page: 1149
  year: 2004
  ident: ref_111
  article-title: Induction of TH1-like regulatory cells that express Foxp3 and protect against airway hyperreactivity
  publication-title: Nat. Immunol.
  doi: 10.1038/ni1122
– volume: 243
  start-page: 110351
  year: 2022
  ident: ref_97
  article-title: An allergen-fused dendritic cell-binding peptide enhances in vitro proliferation of equine T-cells and cytokine production
  publication-title: Vet. Immunol. Immunopathol.
  doi: 10.1016/j.vetimm.2021.110351
– volume: 278
  start-page: 667
  year: 2000
  ident: ref_83
  article-title: IL-10 reduces Th2 cytokine production and eosinophilia but augments airway reactivity in allergic mice
  publication-title: Am. J. Physiol. Lung Cell Mol. Physiol.
  doi: 10.1152/ajplung.2000.278.4.L667
– volume: 172
  start-page: 1777
  year: 2004
  ident: ref_87
  article-title: Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.172.3.1777
– ident: ref_9
  doi: 10.1055/b-004-129693
– volume: 23
  start-page: 15170
  year: 2019
  ident: ref_105
  article-title: Antigen array for serological diagnosis and novel allergen identification in severe equine asthma
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-51820-7
– ident: ref_28
– ident: ref_53
– volume: 3
  start-page: 325
  year: 2003
  ident: ref_54
  article-title: Environmental exposure to endotoxin and other microbial products and the decreased risk of childhood atopy: Evaluating developments since April 2002
  publication-title: Curr. Opin. Allergy Clin. Immunol.
  doi: 10.1097/00130832-200310000-00001
– ident: ref_3
– volume: 45
  start-page: 306
  year: 1999
  ident: ref_42
  article-title: Therapeutic efficacy of inhaled fluticasone propionate in horses with chronic obstructive pulmonary disease
  publication-title: Proc. Am. Ass. Equine Practnrs.
– volume: 20
  start-page: 709
  year: 2002
  ident: ref_59
  article-title: CpG motifs in bacterial DNA and their immune effects
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.immunol.20.100301.064842
– volume: 40
  start-page: 97
  year: 2020
  ident: ref_57
  article-title: Effects of hypersensitivity disorders and environmental factors on the equine intestinal microbiota
  publication-title: Vet. Q.
  doi: 10.1080/01652176.2020.1745317
– volume: 162
  start-page: 2368
  year: 1997
  ident: ref_90
  article-title: Immunostimulatory CpG-Oligodeoxynucleotides cause extramedullary murine hemopoiesis
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.162.4.2368
– volume: 139
  start-page: 186
  year: 2009
  ident: ref_113
  article-title: Immunology taught by lung dendritic cells
  publication-title: Swiss Med. Wkly.
– volume: 117
  start-page: 433
  year: 2006
  ident: ref_82
  article-title: Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: The role of Tregulatory cells
  publication-title: Immunology
  doi: 10.1111/j.1365-2567.2006.02321.x
– volume: 29
  start-page: 1650
  year: 2012
  ident: ref_75
  article-title: A nebulized gelatin nanoparticle-based CpG formulation is effective in Immunotherapy of allergic horses
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-012-0686-8
– volume: 39
  start-page: 562
  year: 2009
  ident: ref_89
  article-title: Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: A phase I/IIa clinical trial
  publication-title: Clin. Exp. Allergy
  doi: 10.1111/j.1365-2222.2008.03191.x
– ident: ref_73
– volume: 23
  start-page: 136
  year: 1991
  ident: ref_8
  article-title: An investigation of the incidence of chronic obstructive pulmonary disease (COPD) in random populations of Swiss horses
  publication-title: Equine Vet. J.
  doi: 10.1111/j.2042-3306.1991.tb02738.x
– volume: 61
  start-page: 233
  year: 2009
  ident: ref_86
  article-title: Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2008.12.014
– volume: 11
  start-page: 1369
  year: 2000
  ident: ref_19
  article-title: Interleukin-8 concentration and neutrophil chemotactic activity in bronchoalveolar lavage fluid of horses with chronic obstructive pulmonary disease following exposure to hay
  publication-title: Am. J. Vet. Res.
  doi: 10.2460/ajvr.2000.61.1369
– volume: 144
  start-page: 79
  year: 2011
  ident: ref_74
  article-title: Immunostimulation of bronchoalveolar Lavage cells from recurrent airway obstruction-affected horses by different CpG-classes bound to gelatin nanoparticles
  publication-title: Vet. Immunol. Immunopathol.
  doi: 10.1016/j.vetimm.2011.07.009
– ident: ref_25
– volume: 66
  start-page: 1665
  year: 2005
  ident: ref_43
  article-title: Randomized, controlled study of inhaled fluticasone propionate, oral administration of prednisone, and environmental management of horses with recurrent airway obstruction
  publication-title: Am. J. Vet. Res.
  doi: 10.2460/ajvr.2005.66.1665
– volume: 181
  start-page: 2990
  year: 2008
  ident: ref_88
  article-title: Targeting CpG oligodeoxynucleotides to the lymph node by nanoparticles elicits efficient antitumoral immunity
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.181.5.2990
– volume: 47
  start-page: 390
  year: 2015
  ident: ref_30
  article-title: Genetics of upper and lower airway diseases in the horse
  publication-title: Equine Vet. J.
  doi: 10.1111/evj.12289
– volume: 29
  start-page: 118
  year: 2017
  ident: ref_102
  article-title: Preliminary evaluation of cytosine-phosphate-guanine oligodeoxynucleotides bound to gelatine nanoparticles as immunotherapy for canine atopic dermatitis
  publication-title: Vet. Rec.
  doi: 10.1136/vr.104230
– volume: 130
  start-page: 4S
  year: 2006
  ident: ref_1
  article-title: The global burden of asthma
  publication-title: Chest
  doi: 10.1378/chest.130.1_suppl.4S
– volume: 39
  start-page: 279
  year: 2007
  ident: ref_51
  article-title: Immunotherapy of asthma using CpG Oligodeoxynucleotides
  publication-title: Immunol. Res.
  doi: 10.1007/s12026-007-0083-2
– volume: 30
  start-page: 152
  year: 1998
  ident: ref_39
  article-title: Effects of inhaled beclomethasone dipropionate on respiratory function in horses with chronic obstructive pulmonary disease (COPD)
  publication-title: Equine Vet. J.
  doi: 10.1111/j.2042-3306.1998.tb04475.x
– volume: 173
  start-page: 4433
  year: 2004
  ident: ref_80
  article-title: Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+ CD 25+ regulatory T cells
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.173.7.4433
– volume: 25
  start-page: 1
  year: 2007
  ident: ref_95
  article-title: The effect of CpG-ODN on antigen presenting cells of the foal
  publication-title: J. Immune Based Ther. Vaccines
  doi: 10.1186/1476-8518-5-1
– volume: 66
  start-page: 245
  year: 1998
  ident: ref_15
  article-title: Studies on pulmonary and systemic Aspergillus fumigatus-specific IgE and IgG antibodies in horses affected with chronic obstructive pulmonary disease (COPD)
  publication-title: Vet. Immunol. Immunopathol.
  doi: 10.1016/S0165-2427(98)00202-5
– volume: 292
  start-page: 1068
  year: 2009
  ident: ref_65
  article-title: Expression of Toll-Like Receptor 9 in Horse Lungs
  publication-title: Anat. Rec.
  doi: 10.1002/ar.20927
– volume: 16
  start-page: 61
  year: 2005
  ident: ref_101
  article-title: Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis—A pilot study
  publication-title: Vet. Dermatol.
  doi: 10.1111/j.1365-3164.2005.00426.x
– volume: 60
  start-page: 189
  year: 2019
  ident: ref_58
  article-title: Lung microbiome is influenced by the environment and asthmatic status in an equine model of asthma
  publication-title: Am. J. Resp. Cell Mol. Biol.
  doi: 10.1165/rcmb.2017-0228OC
– volume: 105
  start-page: 25
  year: 2005
  ident: ref_26
  article-title: Chronic exacerbation of equine heaves is associated with an increased expression of interleukin-17 mRNA in bronchoalveolar lavage cells
  publication-title: Vet. Immunol. Immunopathol.
  doi: 10.1016/j.vetimm.2004.12.013
– volume: 68
  start-page: 455
  year: 2000
  ident: ref_84
  article-title: The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.68.4.455
– volume: 129
  start-page: 198
  year: 2002
  ident: ref_70
  article-title: CpG motifs as possible adjuvants for the treatment of allergic diseases
  publication-title: Int. Arch. Allergy Immunol.
  doi: 10.1159/000066771
– volume: 16
  start-page: 1027
  year: 2011
  ident: ref_2
  article-title: Heaves, an asthma-like disease of horses
  publication-title: Respirology
  doi: 10.1111/j.1440-1843.2011.02033.x
– ident: ref_34
  doi: 10.3390/ani12060744
– volume: 114
  start-page: 103
  year: 2006
  ident: ref_99
  article-title: Formulation with CpG-ODN enhances antibody responses to an equine influenza virus vaccine
  publication-title: Vet. Immunol. Immunopathol.
  doi: 10.1016/j.vetimm.2006.07.013
– volume: 25
  start-page: 551
  year: 2008
  ident: ref_72
  article-title: Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-007-9410-5
– volume: 47
  start-page: 589
  year: 2012
  ident: ref_45
  article-title: Corticosteroids and antigen avoidance decrease airway smooth muscle mass in an equine asthma model
  publication-title: Am. J. Respir. Cell Mol. Biol.
  doi: 10.1165/rcmb.2011-0363OC
– volume: 29
  start-page: 286
  year: 2015
  ident: ref_76
  article-title: Nanoparticulate CpG immunotherapy in RAO-affected horses: Phase I and IIa study
  publication-title: J. Vet. Intern. Med.
  doi: 10.1111/jvim.12524
– volume: 97
  start-page: 1
  year: 2004
  ident: ref_106
  article-title: Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2004.02.022
– volume: 132
  start-page: 21
  year: 2009
  ident: ref_18
  article-title: IgE in horses: Occurrence in health and disease
  publication-title: Vet. Immunol. Immunopathol.
  doi: 10.1016/j.vetimm.2009.09.011
– volume: 94
  start-page: e01337-19
  year: 2020
  ident: ref_98
  article-title: CpG Dinucleotides Inhibit HIV-1 Replication through Zinc Finger Antiviral Protein (ZAP)-Dependent and -Independent Mechanisms
  publication-title: J. Virol.
  doi: 10.1128/JVI.01337-19
– volume: Volume 31
  start-page: 229
  year: 2001
  ident: ref_112
  article-title: Oligodeoxynucleotides
  publication-title: New Drugs for Asthma, Allergy and COPD
  doi: 10.1159/000062171
– volume: 28
  start-page: 315
  year: 2008
  ident: ref_63
  article-title: The DNA sugar backbone 2`deoxyribose determines toll-like receptor 9 activation
  publication-title: Immunity
  doi: 10.1016/j.immuni.2008.01.013
– volume: 119
  start-page: 1258
  year: 2007
  ident: ref_110
  article-title: Quantitative and functional impairment of pulmonary CD4+ CD25hi regulatory T cells in pediatric asthma
  publication-title: J. Allergy Clin. Immunol.
  doi: 10.1016/j.jaci.2007.02.023
– volume: 23
  start-page: 1247
  year: 2009
  ident: ref_44
  article-title: Fluticasone propi- onate aerosol is more effective for prevention than treatment of recurrent airway obstruction
  publication-title: J. Vet. Intern. Med.
  doi: 10.1111/j.1939-1676.2009.0382.x
– volume: 34
  start-page: 17
  year: 2002
  ident: ref_48
  article-title: Efficacy of three corticosteroids for the treatment of heaves
  publication-title: Equine Vet. J.
  doi: 10.2746/042516402776181105
– volume: 51
  start-page: 401
  year: 2019
  ident: ref_38
  article-title: Efficacy of inhaled budesonide for the treatment of severe equine asthma
  publication-title: Equine Vet. J.
  doi: 10.1111/evj.13018
– volume: 59
  start-page: 1039
  year: 1998
  ident: ref_46
  article-title: Pulmonary function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively
  publication-title: Am. J. Vet. Res.
  doi: 10.2460/ajvr.1998.59.08.1039
– ident: ref_61
– volume: 96
  start-page: 83
  year: 2003
  ident: ref_24
  article-title: Recurrent airway obstruction (RAO) in horses is characterized by IFN-γ and IL-8 production in bronchoalveolar lavage cells
  publication-title: Vet. Immunol. Immunopathol.
  doi: 10.1016/S0165-2427(03)00142-9
– volume: 64
  start-page: 335
  year: 2009
  ident: ref_85
  article-title: Regulatory T cells in in bronchial asthma
  publication-title: Allergy
  doi: 10.1111/j.1398-9995.2009.01972.x
– volume: 63
  start-page: 579
  year: 2002
  ident: ref_47
  article-title: Comparison of effects of dexamethasone and the leukotriene D4 receptor antagonist L-708,738 on lung function and airway cytologic findings in horses with recurrent airway obstruction
  publication-title: Am. J. Vet. Res.
  doi: 10.2460/ajvr.2002.63.579
– volume: 22
  start-page: 56
  year: 2018
  ident: ref_103
  article-title: The revival of CpG oligonucleotide-based cancer immunotherapies
  publication-title: Contemp. Oncol.
– volume: 97
  start-page: 87
  year: 2004
  ident: ref_21
  article-title: IL-4, IL-5 and IFN-gamma mRNA-expression in pulmonary lymphocytes in equine heaves
  publication-title: Vet. Immunol. Immunopathol.
  doi: 10.1016/j.vetimm.2003.08.013
– volume: 30
  start-page: 3476
  year: 2009
  ident: ref_93
  article-title: The use of biotinylated-EGF-modified gelatine nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2009.03.010
– volume: 61
  start-page: 256
  year: 2009
  ident: ref_64
  article-title: Use of CpG oligonucleotides in treatment of asthma and allergic disease
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2008.12.007
– volume: 5
  start-page: 61
  year: 2018
  ident: ref_107
  article-title: Comparison of tracheal wash and bronchoalveolar lavage cytology in154 horses with and without respiratory signs in a referral hospital over 2009–2015
  publication-title: Front. Vet. Sci.
  doi: 10.3389/fvets.2018.00061
– volume: 212
  start-page: 238
  year: 2006
  ident: ref_52
  article-title: The regulation of allergy and asthma
  publication-title: Immunol. Rev.
  doi: 10.1111/j.0105-2896.2006.00413.x
– volume: 180
  start-page: 256
  year: 2008
  ident: ref_81
  article-title: Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signalling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.180.6.3797
– ident: ref_17
– volume: 32
  start-page: 2088
  year: 2018
  ident: ref_11
  article-title: Equine asthma: Integrative biologic relevance of a recently proposed nomenclature
  publication-title: J. Vet. Intern. Med.
  doi: 10.1111/jvim.15302
– volume: 56
  start-page: 1
  year: 2011
  ident: ref_5
  article-title: Recurrent airway obstruction in horses—An allergic inflammation: A review
  publication-title: Vet Med.
  doi: 10.17221/1566-VETMED
– volume: 35
  start-page: 322
  year: 1964
  ident: ref_6
  article-title: Observations on heaves. An asthma-like syndrome in the horse
  publication-title: J. Allergy Clin. Immunol.
– volume: 219
  start-page: 6
  year: 2017
  ident: ref_96
  article-title: In vitro effects of the toll-like receptor agonists monophosphoryl lipid A and CpG-rich oligonucleotides on cytokine production by equine cells
  publication-title: Vet. J.
  doi: 10.1016/j.tvjl.2016.11.013
– volume: 29
  start-page: 615
  year: 2012
  ident: ref_94
  article-title: Towards an inhalative in vivo application of immunomodulating gelatin nanoparticles in horse-related preformulation studies
  publication-title: J. Microencapsul.
  doi: 10.3109/02652048.2012.668962
– volume: 12
  start-page: 13
  year: 2000
  ident: ref_60
  article-title: Toll signaling pathways in the innate immune response
  publication-title: Curr. Opin. Immunol.
  doi: 10.1016/S0952-7915(99)00045-X
– volume: 5
  start-page: 190
  year: 2004
  ident: ref_67
  article-title: TLR9 signals after translocating from the ER to CpG DNA in the lysosome
  publication-title: Nat. Immunol.
  doi: 10.1038/ni1028
– volume: 102
  start-page: 103433
  year: 2021
  ident: ref_104
  article-title: Comparison of four different allergy tests in equine asthma affected horses and allergen inhalation provocation test
  publication-title: J. Equine Vet. Sci.
  doi: 10.1016/j.jevs.2021.103433
– volume: 28
  start-page: 419
  year: 2008
  ident: ref_114
  article-title: CpG-induced stimulation of cytokine expression by peripheral blood mononuclear cells of foals and their dams
  publication-title: J. Jevs.
– volume: 25
  start-page: 327
  year: 2009
  ident: ref_50
  article-title: Möglichkeiten der Inhalationstherapie zur Behandlung der chronisch obstruktiven Bronchitis des Pferdes
  publication-title: Pferdeheilkunde
  doi: 10.21836/PEM20090405
– volume: 35
  start-page: 1869
  year: 2005
  ident: ref_91
  article-title: Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.200526124
– volume: 46
  start-page: 276
  year: 2014
  ident: ref_32
  article-title: Recurrent airway obstruction: A review
  publication-title: Equine Vet. J.
  doi: 10.1111/evj.12204
– volume: 61
  start-page: 195
  year: 2009
  ident: ref_71
  article-title: Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2008.12.008
– volume: 19
  start-page: 11
  year: 2008
  ident: ref_33
  article-title: A review of recurrent airway obstruction and summer pasture associated obstructive pulmonary disease
  publication-title: Ippologia
– volume: 124
  start-page: 783
  year: 2006
  ident: ref_62
  article-title: Pathogen recognition and innate immunity
  publication-title: Cell
  doi: 10.1016/j.cell.2006.02.015
– volume: 12
  start-page: 590054
  year: 2021
  ident: ref_116
  article-title: CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2021.590054
– volume: 30
  start-page: 503
  year: 2016
  ident: ref_4
  article-title: Inflammatory Airway Disease of Horses—Revised Consensus Statement. ACVIM Consensus Statement
  publication-title: J. Vet. Intern. Med.
  doi: 10.1111/jvim.13824
– volume: 36
  start-page: 243
  year: 2020
  ident: ref_31
  article-title: Genetics of Equine Respiratory Disease
  publication-title: Vet. Clin. N. Am. Equine Pract.
  doi: 10.1016/j.cveq.2020.03.005
– volume: 7
  start-page: 450
  year: 2020
  ident: ref_10
  article-title: Equine Asthma: Current Understanding and Future Directions
  publication-title: Front. Vet. Sci.
  doi: 10.3389/fvets.2020.00450
– volume: 39
  start-page: 301
  year: 2007
  ident: ref_7
  article-title: A survey of horse owners in Great Britain regarding horses in their care. Part 2: Risk factors for recurrent airway obstruction
  publication-title: Equine Vet. J.
  doi: 10.2746/042516407X180129
– volume: 86
  start-page: 116
  year: 2022
  ident: ref_109
  article-title: A CONSORT-guided, randomized, double-blind, controlled pilot clinical trial of inhaled lidocaine for the treatment of equine asthma
  publication-title: Can. J. Vet. Res.
– ident: ref_13
  doi: 10.3390/genes11101143
– volume: 164
  start-page: 1410
  year: 2001
  ident: ref_20
  article-title: Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/ajrccm.164.8.2012091
– volume: 2
  start-page: 72
  year: 2015
  ident: ref_108
  article-title: Is the Allergen Really Needed in Allergy Immunotherapy?
  publication-title: Curr. Treat. Options Allergy
  doi: 10.1007/s40521-014-0038-5
– volume: 29
  start-page: 3014
  year: 2008
  ident: ref_92
  article-title: Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatine nanoparticles administered via aerosol delivery in nude mice with lung cancer
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2008.03.033
– volume: 51
  start-page: 779
  year: 2019
  ident: ref_37
  article-title: Effect of different doses of inhaled ciclesonide on lung function, clinical signs related to airflow limitation and serum cortisol levels in horses with experimentally induced mild to severe airway obstruction
  publication-title: Equine Vet. J.
  doi: 10.1111/evj.13093
– volume: 66
  start-page: 97
  year: 2015
  ident: ref_12
  article-title: Asthma “of horses and men”—How can equine heaves help us better understand human asthma immunopathology and its functional consequences?
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2014.12.005
– volume: 374
  start-page: 546
  year: 1995
  ident: ref_69
  article-title: CpG motifs in bacterial DNA trigger direct B-cell activation
  publication-title: Nature
  doi: 10.1038/374546a0
– volume: 42
  start-page: 142
  year: 2010
  ident: ref_35
  article-title: Relationship of horse owner assessed respiratory signs index to characteristics of recurrent airway obstruction in two Warmblood families
  publication-title: Equine Vet. J.
  doi: 10.2746/042516409X479586
– volume: 321
  start-page: 209
  year: 1986
  ident: ref_66
  article-title: CpG-rich islands and the function of DNA methylation
  publication-title: Nature
  doi: 10.1038/321209a0
– volume: 60
  start-page: 177
  year: 2005
  ident: ref_55
  article-title: Exposure to pets, and the association with hay fever, asthma, and atopic sensitization in rural children
  publication-title: Allergy
  doi: 10.1111/j.1398-9995.2004.00645.x
SSID ssj0000753151
Score 2.2775667
SecondaryResourceType review_article
Snippet Severe equine asthma is the most common globally widespread non-infectious equine respiratory disease (together with its mild and moderate form), which is...
Simple SummarySevere equine asthma is the most common globally widespread non-infectious equine respiratory disease (together with its mild and moderate form),...
SourceID doaj
unpaywall
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 2087
SubjectTerms Airway management
allergy
animal models
anti-allergic agents
Antigens
Asthma
breathing
Cell cycle
Chronic obstructive pulmonary disease
CpG
Cytokines
drug delivery systems
dust
gelatin
gelatinase A
gene expression
Genes
Genotype & phenotype
Granulocytes
Horses
humans
Hyperplasia
immunotherapy
Insect bites
interleukin-10
interleukin-4
interleukin-8
mucus
nanoparticle
nanoparticles
Neutrophils
oligodeoxyribonucleotides
oxygen partial pressure
Parasites
Pathophysiology
Physiology
Remission (Medicine)
Review
Steroids
Urticaria
viscosity
SummonAdditionalLinks – databaseName: DOAJ Open Access Full Text
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fi9QwEA5yIPoi5y-snhLhfBHKNW2aNL6ty523giK4B4cvJckm7Eovu951Oe6P8X91Ju2uW5HzxZcWmiGEZJL5ppn5hpBDxp3UVpjUgq1LuVM6NVzmaWF4hO-qlJjg_OmzOD3jH8_L851SXxgT1tEDdxN3JDyoCDy4VzNeGqdM5CTn1viy0szi6ZtVaseZ-t5dzxVgy7qEvAL8-iMdFixnAmTlwARFpv4BvPwzOPLeOqz0zbVumh3Lc7JPHvSQkY66oT4kd1x4RO5-W8Yf4o_Jz0mY6ybyd1M4K8EJvoyEGgAi6Xj1gU4wA6TPs7qhi0C_OlBfR49_rAFh0tFVO7_Q7-go0ElfIRU6mv5Oy6LjLrOR6jCjX5YthhfhcMLiAl5YS62hgHxpvA7ou6PTTfz6E3J2cjwdn6Z90YXU8qpsUwBkUpQeNr4VqgQTmlcMUETlMqEqbwo4PbV2yHLGmBZ8pnKTa1HaPPPeZzornpK9sAzuGaEK3B1Z-cpy4bm1VmnDbCFnDOyDkMwl5O1mHWrbM5JjYYymBs8EF63eWbSEHG6FVx0Rx9_F3uOCbkWQPTt-AJ2qe52q_6VTCTnYqEPdb-mrOkeeIcEBLibk9bYZNiPesOjglusogzFGAHJvk2FI4g8TmBA5ULXBoIctYTGP1N-Kx9zphLzZKuVts_H8f8zGC3I_x5wP5AEWB2SvvVy7l4DEWvMqbrpf70I0Xw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9swEBZdytheyn4yr93QoHsZmMa2LNuDMdKQrhkslC2FshcjyfIScOU0dRj9Y_a_7k6R3WSMvNhgH8b2ne4-SXffEXIcMJ0IxaWvINb5TGfClywJ_UgyC9-zOMEC528Tfn7Jvl7FV3tk0tbCYFpl6xOtoy5qhWvkJyHSvHAG0frz4sbHrlG4u9q20BCutULxyVKMPSD7ITJj9cj-6Why8b1bdYEAGUGMWxfqRTDfPxFmDpI87GNS3UZosgz-W7Dz36TJRyuzEHe_RVVtRKSzJ-TAQUk6WOv-KdnT5hl5-LO2C-XPyZ-xmYnK8npT8KEwOV5aog0Al3S4-ELHWBni6q_u6NzQHxrMWtPRzQqQJx3cNrNr8ZEODB27zqnwoOl9uRYdriseqTAFvagbTDvC1zHzazhhj7WKAiKmdpvAPY5O27z2F-TybDQdnvuuGYOvWBo3PgC1hMclOATFsxhCa5gGgC5S3edZWsoIvKoQGtnPgkBwVmShDAWPVdgvy7Iv-tFL0jO10a8IzWAalKRlqhgvmVIqEzJQUVIEEDd4EmiPfGj1kCvHVI4NM6ocZiyotHxDaR457oQXa4KO_4udokI7EWTVthfq5a_cDdKcl-CO4MDKrGCx1Jm0_PdMyTJORaA8ctSaQ-6G-m1-b5geedfdhkGKOy_C6HplZTD3CMDvLpkAyf3hB3ok2TK1rZfevmPmM0sJnjFbU-2R951R7vobr3d_yCF5HGKVBzL_8iPSa5Yr_QawVyPfugH1F43CMhI
  priority: 102
  providerName: ProQuest
– databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwELZQJwQv_EYLDGSk8YKUtU4cJ-EFlWpjRWKaRCsNXiLbsWlE5pYuBY3_hf-VOzct7YQmJF5atbm6bno-f5fc9x0h-4ybVGqhQg17XchNLkPF0yiMFffwPU9SJDh_OBHHY_7-LDnbYPFjWSWk4pUP0hEk2SFA_KTLoi4T8DpLu7PSvvneXktiQqBmVIps3x2RABrvkJ3xyWn_E_aUW316ScuLIbvvSlexiAkcaGsj8nr9WyDzaonkrYWbycsfsq439p-ju0SuZr4sO_l6sGjUgf55RdTxf37aPXKnBae0v_Sm--SGcQ_Izc9Tf-n9Ifk1dBNZe6VwClEZ0u25l-4AuEoHs3d0iFyTltF1SStHPxr4HkMPvy0Ay9L-RTM5l69p39Fh24sVBhr9IYDRwZJDSaUr6em0wUImnI6rzuEJu7bVFDA29Tce2uHoaFUp_4iMjw5Hg-Owbe8Qap4lTQjQLxWJhRCjRZ7AZh1lDPBKZnoiz6yKIU5LaVBPjTEpeJlHKpIi0VHPWtuTvfgx6bipM7uE5pBYpZnNNBeWa61zqZiO05LBTiRSZgLyavVfF7rVPscWHHUBORA6RrHhGAHZXxvPlpIffzd7i06zNkGdbv_GdP6laJd9ISwEOHjgNi95okyuvKI-18ommWQ6IHsrlyva4HFRRKhoJDgA04C8WB-GZY_3cqQz04W3wWomgNPX2TBsFwAnMCDpljtvTXr7iKsmXmQ8556lHZCXa8e_7mw8-Ue7p-R2hAQSFBUWe6TTzBfmGcC6Rj1vV-5v-91J6A
  priority: 102
  providerName: Unpaywall
Title Inhalative Nanoparticulate CpG Immunotherapy in Severe Equine Asthma: An Innovative Therapeutic Concept and Potential Animal Model for Human Asthma Treatment
URI https://www.proquest.com/docview/2706064623
https://www.proquest.com/docview/2707601416
https://www.proquest.com/docview/2718378988
https://pubmed.ncbi.nlm.nih.gov/PMC9405334
https://www.mdpi.com/2076-2615/12/16/2087/pdf?version=1660630708
https://doaj.org/article/6f9636f94f9d45be9b212754cbf58a1c
UnpaywallVersion publishedVersion
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2076-2615
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000753151
  issn: 2076-2615
  databaseCode: DOA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVEBS
  databaseName: EBSCO Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 2076-2615
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000753151
  issn: 2076-2615
  databaseCode: ABDBF
  dateStart: 20111201
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2076-2615
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000753151
  issn: 2076-2615
  databaseCode: DIK
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2076-2615
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000753151
  issn: 2076-2615
  databaseCode: M~E
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2076-2615
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000753151
  issn: 2076-2615
  databaseCode: RPM
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 2076-2615
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000753151
  issn: 2076-2615
  databaseCode: BENPR
  dateStart: 20110301
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 2076-2615
  dateEnd: 20250930
  omitProxy: true
  ssIdentifier: ssj0000753151
  issn: 2076-2615
  databaseCode: M48
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NTcBeEF8T2UZlpPGCFKgTx46REOqqjhVpVQWtNHiJHNehRZnbda2gfwz_K2c3Les07YGXRIovH_Kdfb-Lfb8DOKLMCKV5Hmr0dSEzUoU5E1EY58zDd5kIl-B81uGnffb5PDnfglUxzqoDr24N7Vw9qf60fPv7cvERB_wHF3FiyP5O2RGNKI_qqbgHO-iipKvhcFbh_J_L1boYXdsyP-_mPbvwIOYOygux4Zw8h_8G8Ly5bfLh3E7U4pcqy2s-6eQxPKrAJGkstf8Etox9Cve_j_2v8mfwp22HqvTM3gRnUQyPp55qA-ElaU4-kbbLDakysBZkZMlXg4ZtSOtyjtiTNK5mwwv1njQsaVe1U_FBvX8JW6S5zHkkyg5IdzxzG4_c59jRBZ5clbWSICYmfqGgehzprXa2P4f-SavXPA2rcgyhZmkyCxGqCZ4UOCVoLhN0rlFKEV-kps5lWuQxzqtKGcd_RqnibCCjPFI80VG9KIq6qsd7sG3H1rwAIjEQEmmRasYLprWWKqc6FgOKnoMLagJ4s9JDpiuuclcyo8wwZnH6y67pL4CjtfBkSdFxu9ixU-haxPFq-wvj6Y-sGqYZL3BCwgMr5IAluZG5Z8BnOi-SVFEdwOHKHLKVrWaRYyDiDIFkAK_WzThM3dqLsmY89zJu9xHC37tkqKP3xw4MQGyY2sZHb7bY0dCTgkvms6oDeL02yrt6Y_-_33AAu5FLAXG0wPwQtmfTuXmJwGyW12DnuNXpfqn5Hxs1PwTxWr_TbXz7C0fjP1c
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3datswFBZdy-huxn6Zt27ToL0ZmFqyLFuDMtIsXbK2oWwplN54siwvgVROm4SSh9mr7Nl2pNhpMkbueuOALYTjc3R-pPN9B6FdwnQsFc98Bb7OZ1pIP2Mx9cOMufBdRLEFOJ92efucfbuILjbQnxoLY8sqa5voDHVeKrtHvk8tzQtn4K0_j6592zXKnq7WLTRk1VohP3AUYxWw41jPbiGFGx90voC89yg9avWabb_qMuArlkQTHyKQmEcFaLriIgKfQRMCbjPRARdJkYVgLqTUltaLEMlZLmhGJY8UDYqiCGQQwrwP0BYLmYDkb-uw1T37vtjlAYccgk-dAwPDUAT70gwIJZwGtohvyRW6jgErYe6_RZrbUzOSs1s5HC55wKMn6HEVuuLGXNeeog1tnqGHl6XbmH-OfndMXw4djzgGmw3J-I0j9oBgFjdHX3HHIlEqvNcMDwz-oWEZady6nkKkixvjSf9KfsINgztVp1aYqHcHD8PNOcISS5Pjs3Jiy5zs65jBFfzYnm5DDBE4dscS1XS4V9fRv0Dn9yKWl2jTlEa_QlhA2hUnRaIYL5hSSsiMqDDOCfgpHhPtoY-1HFJVMaPbBh3DFDIkK7R0SWge2l0MHs0JQf4_7NAKdDHEsni7G-XNr7QyCikvwPzBhRUiZ1GmReb49pnKiiiRRHlop1aHtDIt4_RuIXjow-IxGAV70iONLqdujK11gmB73RhimwnAB_RQvKJqKy-9-sQM-o6CXDCH4fbQ3kIp132N1-v_yHu03e6dnqQnne7xG_SIWoSJZR3mO2hzcjPVbyHum2TvqsWF0c_7Xs9_Ac-wbYY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGJi4viKsIDDDS9oIUNRfHSZAm1HUtK4Oqgk6aeAmOY9NKndP1oqk_hj_Er-LYdbIWob7tJZWSIyvNOT7n2D7fdxA68ImIGae5yyHWuUSkzM1JHLhhTkz6nkaxBjh_7dHTc_L5IrrYQX8qLIwuq6x8onHURcn1Hnkj0DQvlEC0bkhbFtE_6XycXLm6g5Q-aa3aaTDbZqE4MnRjFuRxJpbXsJybHXVPQPeHQdBpD1qnru044HKSRHMXspGYRhKsntM0gvgRJD6E0ER4NE1kHoLrYExoii_fZ5QUaZAHjEY88KSUHvNCGPcO2tOHX-Ak9o7bvf63escHgnMI8XUFEgzD1GswNfIDnwaeLuhbC4ume8BGyvtvweb9hZqw5TUbj9eiYecRemjTWNxc2d1jtCPUE3T3R2k26Z-i3101ZGPDKY7Bf8PCfGpIPiCxxa3JJ9zVqBSL_VrikcLfBUwpgdtXC8h6cXM2H16yD7ipcNd2bYWBBjdQMdxaoS0xUwXul3Nd8qRfR40u4Uf3dxtjyMaxOaKww-FBVVP_DJ3filqeo11VKvEC4RSWYHEiE06oJJzzlOU-D-PCh5hFY1846H2lh4xblnTdrGOcwWpJKy1bU5qDDmrhyYoc5P9ix1qhtYhm9DY3yumvzDqIjEpwhXAhMi1IlIs0N9z7hOcySpjPHbRfmUNm3cwsu5kUDnpXPwYHoU99mBLlwsjouidIvLfJ-LqxAHxAB8Ubprbx0ptP1Gho6MhTYvDcDjqsjXLb13i5_Y-8RfdgXmdfur2zV-hBoMEmmoCY7qPd-XQhXkMKOM_f2LmF0c_bns5_AahWcbU
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwELZQJwQv_EYLDGSk8YKUtU4cJ-EFlWpjRWKaRCsNXiLbsWlE5pYuBY3_hf-VOzct7YQmJF5atbm6bno-f5fc9x0h-4ybVGqhQg17XchNLkPF0yiMFffwPU9SJDh_OBHHY_7-LDnbYPFjWSWk4pUP0hEk2SFA_KTLoi4T8DpLu7PSvvneXktiQqBmVIps3x2RABrvkJ3xyWn_E_aUW316ScuLIbvvSlexiAkcaGsj8nr9WyDzaonkrYWbycsfsq439p-ju0SuZr4sO_l6sGjUgf55RdTxf37aPXKnBae0v_Sm--SGcQ_Izc9Tf-n9Ifk1dBNZe6VwClEZ0u25l-4AuEoHs3d0iFyTltF1SStHPxr4HkMPvy0Ay9L-RTM5l69p39Fh24sVBhr9IYDRwZJDSaUr6em0wUImnI6rzuEJu7bVFDA29Tce2uHoaFUp_4iMjw5Hg-Owbe8Qap4lTQjQLxWJhRCjRZ7AZh1lDPBKZnoiz6yKIU5LaVBPjTEpeJlHKpIi0VHPWtuTvfgx6bipM7uE5pBYpZnNNBeWa61zqZiO05LBTiRSZgLyavVfF7rVPscWHHUBORA6RrHhGAHZXxvPlpIffzd7i06zNkGdbv_GdP6laJd9ISwEOHjgNi95okyuvKI-18ommWQ6IHsrlyva4HFRRKhoJDgA04C8WB-GZY_3cqQz04W3wWomgNPX2TBsFwAnMCDpljtvTXr7iKsmXmQ8556lHZCXa8e_7mw8-Ue7p-R2hAQSFBUWe6TTzBfmGcC6Rj1vV-5v-91J6A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inhalative+Nanoparticulate+CpG+Immunotherapy+in+Severe+Equine+Asthma%3A+An+Innovative+Therapeutic+Concept+and+Potential+Animal+Model+for+Human+Asthma+Treatment&rft.jtitle=Animals+%28Basel%29&rft.au=Klier%2C+John&rft.au=Fuchs%2C+Sebastian&rft.au=Winter%2C+Gerhard&rft.au=Gehlen%2C+Heidrun&rft.date=2022-08-16&rft.pub=MDPI&rft.eissn=2076-2615&rft.volume=12&rft.issue=16&rft_id=info:doi/10.3390%2Fani12162087&rft_id=info%3Apmid%2F36009677&rft.externalDocID=PMC9405334
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2076-2615&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2076-2615&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2076-2615&client=summon